Kyung Nam Pharm Co.,Ltd.

KOSDAQ:A053950 Stock Report

Market Cap: ₩28.0b

Kyung Nam PharmLtd Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Oh Hwan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950) Stock Rockets 37% As Investors Are Less Pessimistic Than Expected

Aug 19
Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950) Stock Rockets 37% As Investors Are Less Pessimistic Than Expected

Subdued Growth No Barrier To Kyung Nam Pharm Co.,Ltd.'s (KOSDAQ:053950) Price

May 21
Subdued Growth No Barrier To Kyung Nam Pharm Co.,Ltd.'s (KOSDAQ:053950) Price

Does Kyung Nam PharmLtd (KOSDAQ:053950) Have A Healthy Balance Sheet?

Mar 21
Does Kyung Nam PharmLtd (KOSDAQ:053950) Have A Healthy Balance Sheet?

CEO

Oh Hwan

no data

Tenure

Mr. Oh Chang Hwan has been the Chief Executive Officer of Kyung Nam Pharm Co.,Ltd. since January 22, 2013.